GlassScriptPhysician profile
Ganesh R Deshmukh
NPI 1619950631
$5,637.36
in general payments reported to CMS, 2019-2025
20 companies · $752 in 2025
The $752 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $356 · 2021: $518 · 2022: $1,274 · 2023: $1,881 · 2024: $614 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,382 · Travel and Lodging: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.12 |
| Travel and Lodging | $863.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,390.64 | 2021-2024 | Pivox Oblique Lateral Spinal System, Interstim, Clydesdale Ptc Spinal System |
| Takeda Pharmaceuticals U.S.A., INC. | $756.52 | 2019-2025 | Entyvio, Gattex |
| Celgene Corporation | $366.56 | 2021-2024 | Zeposia |
| E.R. Squibb & Sons, L.L.C. | $335.15 | 2021-2022 | |
| Janssen Biotech, INC. | $218.37 | 2021-2025 | Simponi Aria, Simponi, Stelara |
| Medtronic USA, INC. | $203.46 | 2019-2020 | |
| Abbvie INC. | $198.23 | 2025 | |
| Boston Scientific Corporation | $150.75 | 2024-2025 | Axonics, Wavewriter Alpha Prime 16 |
| Axonics, INC. | $141.46 | 2020-2022 | |
| Aroa Biosurgery Incorporated | $128.89 | 2024 | |
| Integra Lifesciences Corporation | $121.80 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Regeneron Healthcare Solutions, INC. | $114.73 | 2022-2023 | Dupixent |
| Covidien LP | $100.64 | 2020 | |
| Kci USA, INC. | $98.14 | 2019 | |
| Tela Bio, INC. | $89.13 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.55 | 2022-2025 | Trulance, Xifaxan |
| Ethicon US, LLC | $50.92 | 2025 | Enseal, Echelon Circular |
| Merck Sharp & Dohme LLC | $49.60 | 2021-2022 | |
| Mimedx Group, INC. | $32.69 | 2025 | |
| Lilly USA, LLC | $20.13 | 2025 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ganesh Deshmukh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.